Beryl Drugs reports standalone net loss of Rs 0.12 crore in the March 2016 quarter

Sales decline 53.33% to Rs 1.61 crore

Net Loss of Beryl Drugs reported to Rs 0.12 crore in the quarter ended March 2016 as against net loss of Rs 0.32 crore during the previous quarter ended March 2015. Sales declined 53.33% to Rs 1.61 crore in the quarter ended March 2016 as against Rs 3.45 crore during the previous quarter ended March 2015.

For the full year,net profit rose 112.50% to Rs 0.17 crore in the year ended March 2016 as against Rs 0.08 crore during the previous year ended March 2015. Sales declined 1.35% to Rs 13.11 crore in the year ended March 2016 as against Rs 13.29 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales1.613.45 -53 13.1113.29 -1 OPM %2.480.29 -4.045.57 - PBDT-0.010.09 PL 0.690.69 0 PBT-0.12-0.19 37 0.280.17 65 NP-0.12-0.32 63 0.170.08 113

Powered by Capital Market - Live News